Identification of low risk of violent crime in severe mental illness with a clinical prediction tool (Oxford Mental Illness and Violence tool [OxMIV]):a derivation and validation study by Fazel, Seena et al.
 
 
University of Birmingham
Identification of low risk of violent crime in severe
mental illness with a clinical prediction tool (Oxford
Mental Illness and Violence tool [OxMIV])
Fazel, Seena; Wolf, Achim; Larsson, Henrik; Lichtenstein, Paul; Mallett, Susan; Fanshawe,
Thomas R
DOI:
10.1016/S2215-0366(17)30109-8
License:
Creative Commons: Attribution (CC BY)
Document Version
Version created as part of publication process; publisher's layout; not normally made publicly available
Citation for published version (Harvard):
Fazel, S, Wolf, A, Larsson, H, Lichtenstein, P, Mallett, S & Fanshawe, TR 2017, 'Identification of low risk of
violent crime in severe mental illness with a clinical prediction tool (Oxford Mental Illness and Violence tool
[OxMIV]): a derivation and validation study', The Lancet Psychiatry, vol. 4, no. 6. https://doi.org/10.1016/S2215-
0366(17)30109-8
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
www.thelancet.com/psychiatry   Published online May 4, 2017   http://dx.doi.org/10.1016/S2215-0366(17)30109-8 1
Articles
Identification of low risk of violent crime in severe mental 
illness with a clinical prediction tool (Oxford Mental Illness 
and Violence tool [OxMIV]): a derivation and validation study
Seena Fazel, Achim Wolf, Henrik Larsson, Paul Lichtenstein, Susan Mallett, Thomas R Fanshawe
Summary
Background Current approaches to stratify patients with psychiatric disorders into groups on the basis of violence risk 
are limited by inconsistency, variable accuracy, and unscalability. To address the need for a scalable and valid tool to 
assess violence risk in patients with schizophrenia spectrum or bipolar disorder, we describe the derivation of a score 
based on routinely collected factors and present findings from external validation.
Methods On the basis of a national cohort of 75 158 Swedish individuals aged 15–65 years with a diagnosis of severe 
mental illness (schizophrenia spectrum or bipolar disorder) with 574 018 patient episodes between Jan 1, 2001, and 
Dec 31, 2008, we developed predictive models for violent offending (primary outcome) within 1 year of hospital discharge 
for inpatients or clinical contact with psychiatric services for outpatients (patient episode) through linkage of population-
based registers. We developed a derivation model to determine the relative influence of prespecified criminal history and 
sociodemographic and clinical risk factors, which are mostly routinely collected, and then tested it in an external validation. 
We measured discrimination and calibration for prediction of violent offending at 1 year using specified risk cutoffs.
Findings Of the cohort of 75 158 patients with schizophrenia spectrum or bipolar disorder, we assigned 58 771 (78%) 
to the derivation sample and 16 387 (22%) to the validation sample. In the derivation sample, 830 (1%) individuals 
committed a violent offence within 12 months of their patient episode. We developed a 16-item model. The strongest 
predictors of violent offending within 12 months were conviction for previous violent crime (adjusted odds ratio 5·03 
[95% CI 4·23–5·98]; p<0·0001), male sex (2·32 [1·91–2·81]; p<0·0001), and age (0·63 per 10 years of age [0·58–0·67]; 
p<0·0001). In external validation, the model showed good measures of discrimination (c-index 0·89 [0·85–0·93]) and 
calibration. For risk of violent offending at 1 year, with a 5% cutoff, sensitivity was 62% (95% CI 55–68) and specificity 
was 94% (93–94). The positive predictive value was 11% and the negative predictive value was more than 99%. We 
used the model to generate a simple web-based risk calculator (Oxford Mental Illness and Violence tool [OxMIV]).
Interpretation We have developed a prediction score in a national cohort of patients with schizophrenia spectrum or 
bipolar disorder, which can be used as an adjunct to decision making in clinical practice by identifying those who are 
at low risk of violent offending. The low positive predictive value suggests that further clinical assessment in 
individuals at high risk of violent offending is required to establish who might benefit from additional risk 
management. Further validation in other countries is needed.
Funding Wellcome Trust and Swedish Research Council.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Although absolute risks of people with schizophrenia 
spectrum and bipolar disorder committing violent 
crime are typically around 5–10% within 5 years of 
diagnosis and most patients are not violent in their 
lifetimes,1,2 violence perpetrated by individuals with 
these disorders is an important preventable cause of 
morbidity. Furthermore, it contributes to stigma and 
the large numbers of people with mental illness in 
prisons.
One of the main approaches to reduce violence risk 
has been to use structured risk assessment tools, which 
range from checklists to complex decision trees, and to 
stratify individuals into high-risk and low-risk groups. 
These tools are used in mental health services, 
especially in forensic psychiatry, and are recommended 
in clinical guidelines.3–5 Such stratification can help 
target resources, tailor treatment and risk management, 
and inform decisions about assertive community 
treatment, hospital treatment, and other services.5
Current risk assessment instruments, however, have 
been limited by low-to-moderate accuracy,6 poor 
reporting standards,7 and inconsistent definitions of 
what constitutes high risk.8 The tools have rarely been 
developed in individuals with psychosis.9 Additionally, 
many have considerable resource implications, with 
current approaches taking around 16 person-hours in 
one forensic psychiatric setting,10 and most instruments 
requiring several hours. By contrast, some areas of 
medicine, in particular cardiovascular medicine, have 
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developed scalable risk prediction scores, such as 
the Framingham Risk Score and QRISK prediction 
algorithm, which can be used in primary and secondary 
care to inform discussions between clinicians and 
individuals about risk.11 A key factor in their widespread 
use is their ease and simplicity. The need for shorter 
violence risk assessments than at present, validated in 
appropriate patient groups, has been highlighted by an 
American Psychiatric Association taskforce.5 To address 
the need for a scalable and valid tool to assess violence 
risk in patients with schizophrenia spectrum and 
bipolar disorder, we describe the derivation of a score 
based on routinely collected factors and present findings 
from external validation.
Methods
Study design and patients
We did a cohort study of individuals aged 15–65 years 
with a diagnosis of severe mental illness (here defined 
as schizophrenia spectrum or bipolar disorder) through 
linkage of population-based registers in Sweden. 
We identified a cohort of 75 158 individuals with 
574 018 recorded patient episodes (424 842 [74%] 
outpatient episodes) between Jan 1, 2001, and 
Dec 31, 2008. The final study cohort consisted of a 
single inpatient or outpatient visit for each patient, 
selected at random (with use of the random number 
generator in Stata version 12), with equal probability. 
We excluded repeat visits because they complicate 
model fitting and interpretation. The study was 
approved by the Regional Ethics Committee at 
Karolinska Institutet (2009/939-31/5).
Procedures
We followed up each individual from the day of their 
patient episode until the first time that they committed 
a violent offence, death, emigration, or end of follow-
up (12 months after their patient episode). We linked 
individuals to national registers to obtain information 
about risk factors, with unique personal identification 
numbers enabling accurate linkage. We obtained socio-
demo graphic factors and information about previous 
violent crime conviction, psychiatric diagnoses, and 
dispensed medication and identified parents and 
siblings of patients to extract historical information (ie, 
before the current patient episode; appendix pp 1–2).
Outcomes
The primary outcome was the occurrence of any violent 
offending within 1 year of hospital discharge for inpatients 
or clinical contact with psychiatric services for outpatients 
(patient episode). We did not consider repeat offences 
by an individual within 1 year. We used conviction data 
because the Swedish criminal code determines that 
individuals are convicted as guilty regardless of mental 
disorder and no plea bargaining is permitted at conviction. 
We defined violent crime as homicide, assault, robbery, 
arson, any sexual offence (rape, sexual coercion, child 
molestation, indecent exposure, or sexual harassment), or 
illegal threats and harassment.
Statistical analysis
We derived the model with logistic regression (appendix 
pp 3–4). On the basis of existing evidence of criminal 
history and sociodemographic and clinical factors,12,13 we 
Research in context
Evidence before this study
We searched MEDLINE from Jan 1, 1946, until Feb 6, 2017, with 
no language or date restrictions, for systematic reviews 
comparing violence risk assessment tools in individuals with a 
diagnosis of severe mental illness (schizophrenia, schizophrenia 
spectrum disorder, bipolar disorder, and other psychotic 
illnesses). We used the following search terms: “violen*” AND 
(“risk” OR “assess*” OR “predict*” OR “tool*” OR “instrument*”) 
AND (“mental*” OR “psychiatr*”) AND “systematic review”. We 
identified two systematic reviews of violence risk instruments in 
psychosis. The first review, published in 2011, was based on ten 
commonly used tools for violence risk in psychiatric populations 
and identified only two instruments validated in 861 patients 
with psychosis. These two instruments reported areas under the 
curves that ranged from 0·60 to 0·77, with little other 
information about performance. A second review, published in 
2016, was based on violence risk tools in Chinese patients with 
psychiatric disorders, and the authors found typically 
poor-to-moderate performance, with areas under the curves of 
between 0·67 and 0·72 using tools developed in high-income 
countries. Current thinking in the field accepts that group data 
can be informative in decision making about individual cases 
and separates risk assessment from risk reduction or 
management. A scalable approach to violence risk assessment 
(Oxford Risk of Recidivism [OxRec] tool) has been published for 
released prisoners, which includes modifiable risk factors.
Added value of this study
We have developed a 16-item tool using mostly routinely 
collected information, with good measures of calibration and 
discrimination (c-index of 0·89 [95% CI 0·85–0·93] in external 
validation), which has been translated into a freely available 
online calculator. The tool should be used solely by clinicians and 
has specific questions about previous diagnoses and treatments.
Implications of all the available evidence
Violence risk assessment with use of an online tool can serve as 
an adjunct to clinical decision making in general adult 
psychiatry, accurately identify patients at low risk of violent 
offending, and help inform decisions about additional risk 
management. General adult psychiatric services could use the 
tool as part of their routine violence risk assessment for new 
patients rather than local tools, which have no evidence base.
See Online for appendix
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grouped variables a priori on the anticipated strength of 
association with the outcome in decreasing levels of 
priority (appendix p 5).14,15 We excluded covariates with 
more than 30% missing data. We made an exception for 
the recent treatment variables, which were unavailable 
before 2006 only because the Prescribed Drug Register 
was not available: the missingness mechanism was thus 
known and thought to be unrelated to the missing values 
themselves. We imputed missing data via multiple 
imputation using chained equations.
We assessed the internal validity of the model using 
bootstrapping to assess its predictive accuracy.16 We used 
bootstrapping to create 100 samples drawn with replace-
ment from the derivation dataset. To test the external 
validation of the model, we selected at random (using 
the sample function in R version 2.3.1) a subsample of 
geographical regions (the validation sample)17 on the 
basis of the residential geographical location of the 
individual at the time of diagnosis, comprising around 
one-fifth of the total sample, and removed it from the 
dataset used to fit the model (the derivation sample). We 
chose the number of regions for the validation sample to 
be large enough for a useful assessment of external 
validity to be made.18 The geographical regions and 
method for selection of the validation sample are 
described in the appendix (p 6).
In external validation, we summarised predictive 
accuracy using: first, the concordance index19 to assess 
discrimination (ability of the model to distinguish 
between those who do and do not commit a violent 
crime, with a value of 1 meaning perfect discrimination); 
second, the Brier score20 for calibration (model goodness 
of fit—whether or not the predicted risk is systematically 
off target, with 0 meaning perfect calibration; the Brier 
score measures the mean squared difference between 
the predicted probability and the actual outcome [violent 
crime or no violent crime]); third, the net reclassification 
index21 (how well a model rightly or wrongly reclassifies 
patients compared with alternative models); and fourth, 
Patients (n=58 771)
Group 1*
Male sex 29 077 (49%)
Age (years) 44 (13)
Previous violent crime 9212 (16%)
Previous drug use 7123 (12%)
Previous alcohol use 8897 (15%)
Previous self-harm 11 510 (20%)
Educational level
Lower secondary (<16 years of age) 17 814/50 752 (35%)
Upper secondary (16–18 years of age) 26 449/50 752 (52%)
Postsecondary (>18 years of age) 6489/50 752 (13%)
Parental drug or alcohol use 5214/47 957 (11%)
Parental violent crime 3203/47 957 (7%)
Sibling violent crime 4028 (7%)
Group 2†
Diagnosis
Schizophrenia spectrum disorder 36 755 (63%)
Bipolar disorder 22 016 (37%)
Recent treatment (within preceding 6 months)
Mood stabiliser 10 390/34 039 (31%)
Antipsychotic 18 401/34 039 (54%)
Antidepressant 13 255/34 039 (39%)
Dependence 1030/34 039 (3%)
Inpatient at time of episode 18 160 (31%)
Length of first inpatient stay >7 days 24 532 (42%)
More than seven patient episodes 16 686 (28%)
Group 3‡
Received benefits§ 37 210/57 876 (64%)
Deprivation
First decile (lowest) 2793/56 617 (5%)
Fifth decile 4862/56 617 (9%)
Tenth decile (highest) 10 769/56 617 (19%)
Never married 34 506/57 459 (60%)
Personal income
First decile (lowest) 5444/57 876 (9%)
Fifth decile 9169/57 876 (16%)
Tenth decile (highest) 2009/57 876 (3%)
Children in household 11 079 (19%)
Parental psychiatric admission to hospital 13 225/47 957 (28%)
Parental suicide 1417/47 957 (3%)
Comorbid depression 11 934/36 755 (32%)¶
Recent death of family member (within 
preceding 6 months)
953/47 957 (2%)
Data are n (%), mean (SD), or n/N (%). *Variables included in the model on the basis 
of previous evidence. †Variables considered for the model with strong evidence, but 
retained in the model if significant. ‡Variables considered for the model with weaker 
evidence, but retained in the model if significant. §Welfare or disability benefits. 
¶Denominator is the number of patients with schizophrenia spectrum disorder. 
Table 1: Baseline characteristics of the derivation sample diagnosed with 
schizophrenia spectrum or bipolar disorder, with grouping of violence 
risk factors
Figure 1: Violent crime over a 12 month period in different populations 
by sex
*Data taken from the general population sample in Fazel and colleagues.1 
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sensitivity and specificity based on a 5% threshold of 
predicted probability. We compared the proportions 
of predicted and observed events at different levels of 
predicted probability using a calibration plot. On the 
basis of research that has found an incidence of violent 
crime in schizophrenia spectrum disorders at 1 year of 
4%,1 we prespecified a 5% cutoff for low-to-high risk of 
violent offending. We used a higher cutoff than this 4% 
incidence as the previous data were based on a younger 
age cohort and only on patients with schizophrenia 
spectrum disorder. We used Stata version 12 and 
R version 3.2.1 for all analyses. We followed the TRIPOD 
statement (appendix p 7).
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had 
full access to all the data in the study and had final 
responsibility for the decision to submit for publication. 
Results
Of the cohort of 75 158 patients with schizophrenia 
spectrum or bipolar disorder, we assigned 58 771 (78%) to 
the derivation sample and 16 387 (22%) to the validation 
sample (table 1). Overall, 869 (2·3%) of 37 221 men and 
181 (0·5%) of 37 937 women committed violent crime 
over a 12 month period (figure 1). In the derivation 
sample, 830 (1%) individuals committed a violent offence 
within 12 months of their patient episode, 1702 (3%) died 
within 12 months, and 40 611 (69%) were outpatients at 
the time of the episode.
We included 16 items in the final model (table 2; 
appendix p 8). The strongest predictors of violent 
offending within 12 months were previous violent crime 
conviction, male sex, and age. The decline in probability 
of violent offending was approximately linearly related 
to increasing age (appendix p 9). Personal income and 
benefit receipt were among the weaker predictors of 
violent offending. Shrinkage effects (a measure of the 
adjustment required for a model fitted to sample data so 
that it does not overestimate predictive performance) 
were negligible: the average estimate of the shrinkage 
heuristic from the bootstrapped samples was 99%. We 
arrived at the final model by including all group 1 
variables and the group 2 and 3 variables that retained 
significance with multivariable analyses.
Figure 2: Model discrimination in the (A) derivation and (B) external 
validation samples
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B
Adjusted odds 
ratio (95% CI)
p value
Male sex 2·32 (1·91–2·81) <0·0001
Age at hospital discharge (per 10 years) 0·63 (0·58–0·67) <0·0001
Previous violent crime* 5·03 (4·23–5·98) <0·0001
Previous drug use† 1·45 (1·23–1·72) <0·0001
Previous alcohol use† 1·75 (1·47–2·09) <0·0001
Previous self-harm† 1·23 (1·04–1·45) 0·02
Educational level ·· 0·31
Lower secondary (<16 years of age) 1 (reference) ··
Upper secondary (16–18 years of age) 0·88 (0·75–1·04) ··
Postsecondary (>18 years of age) 0·93 (0·69–1·26) ··
Parental drug or alcohol use† 1·11 (0·91–1·35) 0·30
Parental violent crime* 1·16 (0·92–1·46) 0·21
Sibling violent crime* 0·90 (0·71–1·13) 0·35
Recent treatment‡—antipsychotic 0·62 (0·51–0·77) <0·0001
Recent treatment‡—antidepressant 0·80 (0·65–0·99) 0·04
Recent treatment‡—dependence§ 1·78 (1·22–2·60) 0·003
Inpatient at time of episode 1·37 (1·18–1·59) <0·0001
Received benefits¶ 1·42 (1·17–1·72) 0·0003
Personal income ·· 0·046
Fifth decile 0·84 (0·65–1·10) ··
Tenth decile (highest) 0·88 (0·50–1·57) ··
*Conviction for homicide, assault, robbery, arson, any sexual offence (rape, sexual 
coercion, child molestation, indecent exposure, or sexual harassment), illegal 
threats, or harassment. †Inpatient or outpatient International Classification of 
Diseases diagnosis in patient register. ‡Dispensed within the last 6 months. §Drugs 
used in addictive disorders. ¶Welfare or disability benefits. 
Table 2: Associations between risk factors and violent crime in the 
derivation sample from the multiple regression model (after multiple 
imputation)
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The model showed good overall discrimination on the 
basis of the results from both internal validation with use 
of bootstrapping (c-index 0·86 [95% CI 0·84–0·89]; Brier 
score 0·0132; net reclassification index 1·14) and external 
validation (c-index 0·89 [0·85–0·93]; Brier score 0·0120; 
net reclassification index 1·28). When we used the 
prespecified 5% risk cutoff for violent crime in 1 year, the 
sensitivity was 49% (95% CI 45–52) and the specificity 
was 94% (94–94) in internal validation. The sensitivity in 
external validation was slightly higher (62% [55–68]) 
than in internal validation, with the same specificity 
(94% [93–94]). The positive predictive value was 11% and 
the negative predictive value was more than 99%. The 
2 × 2 tables used to derive sensitivity are shown in the 
appendix (p 10). Receiver operating characteristic curves 
are shown in figure 2. Calibration plots indicate adequate 
calibration of the predicted probabilities against observed 
proportions of violent offending (figure 3).
We applied the coefficients to develop a web calculator 
called the Oxford Mental Illness and Violence tool 
[OxMIV]), which is free to use. This tool provides both a 
risk classification (low or high) and a probability of violent 
offending within the next 12 months. A beta version of 
the online risk calculator for violent offending (based on 
the coefficients in the appendix [p 8]) can be found online. 
If missing values are present, this calculator reports the 
upper and lower range of estimates of risk.
Discussion
We have described the development of a clinical 
prediction score and web calculator (OxMIV) for risk of 
committing violent crime in individuals with diagnoses 
of schizophrenia spectrum or bipolar disorder with 
good measures of discrimination and calibration. We 
developed a 16-item model from prespecified criminal 
history, socio demographic, and clinical risk factors. The 
prediction score is brief and simple to use, relies on 
information that can be routinely collected, and is able to 
stratify individuals into high-risk and low-risk groups. It 
is primarily intended as an adjunct to clinical decision 
making and to anchor decisions on violence risk using 
an evidence-based approach, which will need to be 
complemented by individualised and contextual factors.22
Current risk assessment tools predicting violence 
risk in psychiatric populations are limited by being 
time-consuming, requiring training, having direct costs 
in most cases, and randomised controlled trial evidence23 
that instruments based on structured clinical judgment 
do not improve patient outcomes. Despite these 
limitations, they are widely used in general and forensic 
psychiatry.24 To our knowledge, none of the current 
approaches use web-based calculators, are free to use, and 
incorporate treatment information. By contrast, OxMIV 
addresses these limitations, and as the derivation sample 
was based on 58 771 patients, it provides substantially 
improved precision for identified risk factors. The 
performance statistics of OxMIV are better than are those 
reported for other instruments currently used in mental 
health. For violent crime over 1 year, the model had a 
sensitivity of 62% and a specificity of 94% in the external 
validation sample with use of prespecified risk thresholds. 
The positive predictive value was 11% and the negative 
predictive value was more than 99%.
Authors of a 2011 systematic review9 found that only 
two instruments had been validated in 861 patients with 
psychosis, with areas under the curves (AUCs) that 
ranged from 0·60 to 0·77, with little other performance 
information. By contrast, the overall c-index (equivalent 
to an AUC) of OxMIV was 0·89 in the external validation. 
A broad review6 of all violence instruments used in 
criminal justice reported a median AUC of 0·72 
(IQR 0·68–0·78), with a sensitivity higher than that of 
OxMIV, at 92%, but a specificity lower, at 36%, with these 
differences in sensitivity and specificity being explained 
by different thresholds used in criminal justice 
populations and in the population of this study. Authors 
of a review25 of commonly used cardiovascular risk scores 
For the OxMIV calculator see 
https://oxrisk.com/oxmiv
Figure 3: Predicted and observed risks of violent crime in the (A) derivation 
and (B) external validation samples
Individuals are grouped by predicted probability, numbers are the number of 
individuals in each grouping, and error bars are 95% CIs for the proportion of 
events in each group.
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reported AUCs in the range of 0·70 to 0·75. Another 
limitation of current approaches is that they might 
increase stigma, particularly by overestimating risks. 
More precision than at present about future probabilities 
of violent crime could partly address this limitation, as 
well as more awareness of the epidemiological evidence 
for actual violence over a 12 month period (figure 1).
One clinical implication of OxMIV is that it could be 
used to screen for low violence risk in general adult 
psychiatric services. This use is facilitated by the high 
negative predictive value (which was was in fact 99·5%)—
in other words, of those identified as low risk, 199 of 200 
did not in fact offend violently within 1 year. But the low 
positive predictive value of the tool means that it should 
not be used to predict violent crime as only around one in 
10 of those identified as high risk will actually violently 
offend. Rather, it can identify patients at higher than 
average risk (figure 4). However, as OxMIV’s sensitivity 
was 62% using the 5% threshold, it can be used to stratify 
patients into low-risk and high-risk groups because nearly 
two-thirds of all those who do violently offend will be 
picked up by this tool. If the consequences of identification 
of someone at high risk are not harmful, then this 
identification has the potential to reduce violence risk. At 
the same time, this identification cannot be used to detain 
individuals or extend their detention in the absence of 
other clinical factors and detailed assessment.
Use of a 5% threshold was based on 1 year postdiagnosis 
incidence data,1 although violence incidence in this 
sample was lower than that in the previous data as it 
included individuals at random points after diagnosis, 
meaning that individuals were older than in previous 
studies. Nevertheless, the 5% threshold might be 
considered low by some clinicians, but thresholds higher 
than 5% will be subject to more false negatives than 
those of 5% or lower. Broadly, use of this score provides a 
framework to make decisions between patients, carers, 
and health-care staff, and allow for anchoring of clinical 
risk in evidence, particularly as clinicians might over-
estimate risk.5 Furthermore, it could replace tools that 
are developed by local or regional general adult 
psychiatric services that have no supporting evidence 
and are often mandatory for clinicians to complete.
In terms of administration of this prediction score, 
including its communication to individuals and linkage 
to treatment, it is important to emphasise that it is only 
an adjunct to clinical decision making and that clinical 
judgment should supplement it with relevant individual 
factors. One strength is that any health-care professional 
can use OxMIV, including nursing, psychology, and 
medical staff, in primary and secondary care, but it 
should not be administered by non-clinical staff as 
it relies on diagnostic and treatment information and 
should only be part of a wider clinical assessment that 
considers other individual factors. The tool can be used 
at any point in a patient’s pathway, apart from in forensic 
psychiatric patients and released prisoners,26 as baseline 
risks and the effects of risk factors will be different. Some 
of the items might not be routinely available, and we 
have provided for the possibility of scoring unknown for 
the socioeconomic and parental items. However, the risk 
factors included underscore the importance of taking a 
full psychiatric history to assist in prognosis.
Strengths of our study include that it was based on a 
total cohort of all patients with diagnosed schizophrenia 
spectrum or bipolar disorder, with high-quality registers 
being linked to provide information about covariates 
and outcomes. Unlike previous risk assessment 
instruments,27 we have reported measures of discrim-
ination and calibration in both derivation and external 
validation populations. Predictive accuracy was similar 
between the derivation and external validation samples, 
with the external validation sample being geographically 
separated from the derivation one. This finding would 
suggest that the model has the potential to be applied 
to different populations. Additionally, our shrinkage 
estimate was 99%, which is higher than the 85% that is 
recommended.16 Another methodological strength was 
use of imputation to replace missing data, which is new 
in the field of violence risk assessment. Finally, we have 
provided a free web calculator version for clinical staff.
A limitation of the study is validation in one country. 
Prevalence estimates for diagnoses of psychotic disorders 
vary minimally across European countries and the 
USA.28–30 In relation to the outcome of violent offending, 
police-recorded rates of serious violent offences, such 
as assault, robbery, and rape, have been shown to be 
fairly similar across high-income countries.31 Some 
miscalibration occurred for individuals at the highest risk 
at 1 year, but only a small number of individuals had a 
very high predicted risk, and predicted scores were not 
consistently higher or lower than observed ones. 
Nevertheless, we dealt with this miscalibration in the 
Figure 4: Observed and predicted risk of violent crime in severe mental illness
NPV=negative predictive value. PPV=positive predictive value. 
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calculator by including a maximum risk of 20% so that 
any individuals with a predicted risk of 20% or higher all 
receive the same risk estimate (≥20%). We did not include 
migration data, which could lead to reduced time at risk 
for some individuals. However, the effects are likely to 
be minimal—in a related cohort of patients with 
schizophrenia spectrum disorders, 0·8% emigrated 
within 12 months of diagnosis.1 Being on medication for 
alcohol and drug misuse was associated with increasing 
risk as it was probably confounded by indication and 
acted as a proxy for severe comorbidity. Furthermore, 
our model does not include information about risk factors 
that could be collected in an interview, including 
specific symptoms,32 premorbid conduct problems, anger, 
victimisation, and comorbid personality disorder, which 
might further enhance the performance of the tool, but at 
the cost of making it more complex and time-consuming 
than without inclusion of this information. We did not 
consider comorbid personality disorders as their validity 
in Swedish registers is not known, but is likely to be low. 
As the tool mostly contains static factors, it should not be 
used to monitor within-individual changes in risk, but 
should be used as a cross-sectional score at a particular 
point in time. Some specific items, such as personal 
income and benefit receipt, might not be easily 
generalisable, but we have allowed for them to be scored 
as unknown and in the fitted model they were fairly weak 
predictors of violent offending. The possibility to include 
missing data addresses one previously highlighted 
concern with existing structured instruments.5
An important issue is the implication of being labelled 
high risk and potential misuses, which could include 
restrictions on freedom (such as detention in hospital) 
and further stigma. The tool always needs to be used in 
conjunction with clinical decision making, and the ethics 
of deprivation of liberty versus risk to others should be 
carefully considered.33 Although the tool is freely available 
online, which allows for its widespread use in clinical 
services, this easy accessibility risks that it could be used 
for the wrong purposes and in the wrong contexts. 
Balancing of these issues will remain a challenge, and 
clear guidelines on the tool’s intended population and 
how it should be used need to be established and regularly 
updated. Another limitation is use of violent crime as the 
primary outcome, which, although generalisable (as 
definitions are common across countries), with clear 
effects on public health, the absolute rates reported for 
violent crime are lower than for any violence, and the risk 
calculator provides a conservative estimate of violence 
risk. Additionally, the tool should not be used to assess 
risk of violence before hospital discharge in inpatients 
with psychiatric disorders, and separate models for 
subgroups of violent crime were not feasible. Future 
research should assess whether or not use of this 
prediction model improves outcomes for individuals 
with severe mental illness by reducing their risk of 
violent offending.
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